Morepen Laboratories Limited (IN:MOREPENLAB)
:MOREPENLAB
Want to see IN:MOREPENLAB full AI Analyst Report?
Total Valuation
Morepen Laboratories Limited has a market cap or net worth of ₹27.49B. The enterprise value is ₹25.08B.
Market Cap₹27.49B
Enterprise Value₹25.08B
Share Statistics
Morepen Laboratories Limited has 547,953,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding547,953,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Morepen Laboratories Limited’s return on equity (ROE) is 0.08 and return on invested capital (ROIC) is 4.69%.
Return on Equity (ROE)0.08
Return on Assets (ROA)0.05
Return on Invested Capital (ROIC)4.69%
Return on Capital Employed (ROCE)0.06
Revenue Per Employee8.39M
Profits Per Employee557.25K
Employee Count2,152
Asset Turnover0.93
Inventory Turnover4.13
Valuation Ratios
The current PE Ratio of Morepen Laboratories Limited is 29.7. Morepen Laboratories Limited’s PEG ratio is -1.01.
PE Ratio29.7
PS Ratio1.13
PB Ratio1.64
Price to Fair Value1.64
Price to FCF-14.14
Price to Operating Cash Flow177.69
PEG Ratio-1.01
Income Statement
In the last 12 months, Morepen Laboratories Limited had revenue of 18.06B and earned 948.77M in profits. Earnings per share was 1.73.
Revenue18.06B
Gross Profit6.82B
Operating Income891.94M
Pretax Income1.20B
Net Income948.77M
EBITDA1.73B
Earnings Per Share (EPS)1.73
Cash Flow
In the last 12 months, operating cash flow was 158.61M and capital expenditures -405.73M, giving a free cash flow of -247.12M billion.
Operating Cash Flow158.61M
Free Cash Flow-247.12M
Free Cash Flow per Share-0.45
Dividends & Yields
Morepen Laboratories Limited pays an annual dividend of ₹0.2, resulting in a dividend yield of 0.49%
Dividend Per Share₹0.2
Dividend Yield0.49%
Payout Ratio11.11%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.83
52-Week Price Change-22.33%
50-Day Moving Average42.67
200-Day Moving Average43.49
Relative Strength Index (RSI)64.64
Average Volume (3m)88.30K
Important Dates
Morepen Laboratories Limited upcoming earnings date is Jul 23, 2026, TBA (Confirmed).
Last Earnings DateMay 26, 2026
Next Earnings DateJul 23, 2026
Ex-Dividend Date―
Financial Position
Morepen Laboratories Limited as a current ratio of 2.37, with Debt / Equity ratio of 16.68%
Current Ratio2.37
Quick Ratio1.82
Debt to Market Cap0.10
Net Debt to EBITDA0.80
Interest Coverage Ratio5.43
Taxes
In the past 12 months, Morepen Laboratories Limited has paid 242.74M in taxes.
Income Tax242.74M
Effective Tax Rate0.20
Enterprise Valuation
Morepen Laboratories Limited EV to EBITDA ratio is 12.61, with an EV/FCF ratio of -15.10.
EV to Sales1.21
EV to EBITDA12.61
EV to Free Cash Flow-15.10
EV to Operating Cash Flow134.28
Balance Sheet
Morepen Laboratories Limited has ₹932.86M in cash and marketable securities with ₹1.58B in debt, giving a net cash position of -₹651.76M billion.
Cash & Marketable Securities₹932.86M
Total Debt₹1.58B
Net Cash-₹651.76M
Net Cash Per Share-₹1.19
Tangible Book Value Per Share₹20.57
Margins
Gross margin is 37.78%, with operating margin of 4.94%, and net profit margin of 5.25%.
Gross Margin37.78%
Operating Margin4.94%
Pretax Margin6.64%
Net Profit Margin5.25%
EBITDA Margin9.57%
EBIT Margin7.55%
Analyst Forecast
The average price target for Morepen Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-0.32%
EPS Growth Forecast-22.18%